Date:12/3/2010

ts of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to natural disasters, pandemic outbreaks, or terrorist acts; effect on liquidity of the Company's debt service requirements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended January 3, 2010, as supplemented in the Company's quarterly report on Form 10-Q for the second quarter ended July 4, 2010.Financial and Investor Contact:
Eric Slusser 770-951-6101eric.slusser@gentiva.comor John Mongelli770-221-6700john.mongelli@gentiva.comMedia Contact:Scott CianciulliBrainerd Communicators212-986-6667cianciulli@braincomm.com
'/>"/>

SOURCE Gentiva Health Services, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Crescent Healthcare Expands East Coast Presence
2. HeartWare to Present at the 22nd Annual Piper Jaffray Health Care Conference
3. Ridge Diagnostics, Inc. Presents Clinical Data on Blood Test for Depression at U.S. Psychiatric and Mental Health Congress
4. Chimerix Presents Update on CMX001 Development to the World Health Organization Advisory Committee on Variola Virus Research
5. The Israeli Governments Ministry of Health Invites Medisafe 1 Technologies to Demonstrate its Unique Syringe Locking Device Technology
6. Keryx Biopharmaceuticals to Present at Lazard Capital Markets 7th Annual Healthcare Conference
7. Intarcia Therapeutics Executive Chairman, Kurt Graves to Present at Lazard Capital Markets 7th Annual Healthcare Conference
8. Argos Therapeutics to Present Corporate Overview and Next Steps in Clinical Development of Arcelis™ Immunotherapy at Lazard Capital Markets 7th Annual Healthcare Conference
9. Accuray Incorporated to Speak at Seventh Annual Lazard Capital Markets Healthcare Conference
10. Anadys Pharmaceuticals to Present at the Lazard Healthcare Conference
11. Marshall Edwards CEO to Present at Lazard Capital Markets Healthcare Conference